- Home
- IDYA vs SBLK Comparison
IDYA vs SBLK Comparison
Compare IDYA & SBLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- SBLK
- Stock Information
- Founded
- IDYA 2015
- SBLK 2006
- Country
- IDYA United States
- SBLK Greece
- Employees
- IDYA N/A
- SBLK N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- SBLK Marine Transportation
- Sector
- IDYA Health Care
- SBLK Consumer Discretionary
- Exchange
- IDYA Nasdaq
- SBLK Nasdaq
- Market Cap
- IDYA 2.0B
- SBLK 1.9B
- IPO Year
- IDYA 2019
- SBLK N/A
- Fundamental
- Price
- IDYA $17.05
- SBLK $15.98
- Analyst Decision
- IDYA Strong Buy
- SBLK Strong Buy
- Analyst Count
- IDYA 13
- SBLK 3
- Target Price
- IDYA $53.58
- SBLK $22.67
- AVG Volume (30 Days)
- IDYA 887.8K
- SBLK 2.3M
- Earning Date
- IDYA 05-06-2025
- SBLK 05-21-2025
- Dividend Yield
- IDYA N/A
- SBLK 13.39%
- EPS Growth
- IDYA N/A
- SBLK 60.00
- EPS
- IDYA N/A
- SBLK 2.80
- Revenue
- IDYA $7,000,000.00
- SBLK $1,265,458,000.00
- Revenue This Year
- IDYA $89.14
- SBLK N/A
- Revenue Next Year
- IDYA $291.34
- SBLK $18.23
- P/E Ratio
- IDYA N/A
- SBLK $5.68
- Revenue Growth
- IDYA N/A
- SBLK 33.31
- 52 Week Low
- IDYA $16.88
- SBLK $14.30
- 52 Week High
- IDYA $44.42
- SBLK $27.47
- Technical
- Relative Strength Index (RSI)
- IDYA 31.80
- SBLK 48.24
- Support Level
- IDYA $17.05
- SBLK $16.38
- Resistance Level
- IDYA $18.90
- SBLK $17.34
- Average True Range (ATR)
- IDYA 0.91
- SBLK 0.47
- MACD
- IDYA 0.01
- SBLK -0.08
- Stochastic Oscillator
- IDYA 6.27
- SBLK 37.04
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.
About SBLK Star Bulk Carriers Corp.
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.